ITSA, exactly when did the MD say "that the "interim" results for Atl 1103 for Acromegaly were a good indication and good enough to get the ball rolling with interested parties"
Looking back to March /April I cannot see that statement, which I believe was actually said over 10 months ago on 23rd December.
23rd Dec "Based on these interim results,the Company will be following up interest from pharmaceutical companies in partnering the development of ATL1103 for Phase III clinical trials."
The next indication of any interested parties was when they hired Destum, because of his incompetance to do what we pay him for. I honestly hope the board is looking at the MD to replace as per their latest notice
"Board continues to evaluate its performance and based on current clear future direction expects to make Board changes"
AGM Presentatio, page-21
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |